1. Home
  2. PAR vs YDES Comparison

PAR vs YDES Comparison

Compare PAR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$13.86

Market Cap

588.2M

Sector

Miscellaneous

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$5.19

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
YDES
Founded
1968
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Sector
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
588.2M
543.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
PAR
YDES
Price
$13.86
$5.19
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$33.20
N/A
AVG Volume (30 Days)
1.3M
20.4K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$455,547,000.00
N/A
Revenue This Year
$9.82
N/A
Revenue Next Year
$11.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.16
N/A
52 Week Low
$11.59
$4.73
52 Week High
$72.15
$25.00

Technical Indicators

Market Signals
Indicator
PAR
YDES
Relative Strength Index (RSI) 47.47 39.29
Support Level $12.47 N/A
Resistance Level $14.37 $13.19
Average True Range (ATR) 0.75 0.39
MACD 0.18 0.08
Stochastic Oscillator 39.83 35.14

Price Performance

Historical Comparison
PAR
YDES

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: